Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis.

Yosuf El-Shabrawi; Josef Hermann

doi:10.1016%2FS0161-6420%2802%2901292-7

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis.

Yosuf El-Shabrawi^* (Erstautor*in)
, Josef Hermann (Letztautor*in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

96 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Ophthalmology
DOIs	https://doi.org/10.1016%2FS0161-6420%2802%2901292-7
Publikationsstatus	Veröffentlicht - 2002

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1016%2FS0161-6420%2802%2901292-7

Andere Dateien und Links

Dieses zitieren

@article{3388523c5ebb4018ae2a63ecf553b761,

title = "Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis.",

author = "Yosuf El-Shabrawi and Josef Hermann",

year = "2002",

doi = "10.1016\%2FS0161-6420\%2802\%2901292-7",

language = "English",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis.

A2 - El-Shabrawi, Yosuf

A2 - Hermann, Josef

PY - 2002

Y1 - 2002

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000179652000028

UR - https://pubmed.ncbi.nlm.nih.gov/12466181

U2 - 10.1016%2FS0161-6420%2802%2901292-7

DO - 10.1016%2FS0161-6420%2802%2901292-7

M3 - Research article

C2 - 12466181

SN - 0161-6420

JO - Ophthalmology

JF - Ophthalmology

ER -